Decoding FDA Complete Response Letters: Regulatory Challenges and Strategies for Successful Drug Approval
A Complete Response Letter (CRL) is provided by the U.S. Food and Drug Administration (FDA) when a marketing application is deemed unprovable in its existing format. Although CRLs hold important regulatory implications, there is a lack of comprehensive analytical frameworks for their assessment. To develop a systemati...